2-fluoromethylornithine has been researched along with Neuroblastoma in 1 studies
*Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KY; Liu, AY; Nau, D | 1 |
1 other study(ies) available for 2-fluoromethylornithine and Neuroblastoma
| Article | Year |
|---|---|
Effects of inhibitors of ornithine decarboxylase on the differentiation of mouse neuroblastoma cells.
Topics: Acetylcholinesterase; Animals; Bucladesine; Carboxy-Lyases; Cell Differentiation; Drug Synergism; Eflornithine; Mice; Neuroblastoma; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines | 1983 |